low-strength anthralin 's mode of action in psoriasis is suggested to involve regression of a series of systems , including prevention of mast cell degranulation , thereby inhibiting release of histamine , proteinase and other mast cell mediators sustaining the psoriatic process .
C0003166
anthralin 's
C0033860
psoriasis